These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15935831

  • 1. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.
    Nordenhem A, Leander K, Hallqvist J, de Faire U, Sten-Linder M, Wiman B.
    Thromb Res; 2005; 116(3):223-32. PubMed ID: 15935831
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [Abstract] [Full Text] [Related]

  • 3. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction.
    Lundblad D, Dinesen B, Rautio A, Røder ME, Eliasson M.
    J Intern Med; 2005 Jul; 258(1):13-20. PubMed ID: 15953128
    [Abstract] [Full Text] [Related]

  • 4. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C.
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [Abstract] [Full Text] [Related]

  • 5. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO, Jansson JH, Nyhlén KA, Nilsson TK.
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [Abstract] [Full Text] [Related]

  • 6. Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program.
    Janszky I, Hallqvist J, Tomson T, Ahlbom A, Mukamal KJ, Ahnve S.
    Brain; 2009 Oct; 132(Pt 10):2798-804. PubMed ID: 19717532
    [Abstract] [Full Text] [Related]

  • 7. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM, Nilsson TK, Weinehall L, Boman K, Eliasson M, Hallmans G, Jansson JH.
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [Abstract] [Full Text] [Related]

  • 8. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N, Maguire TM, Riisbro R, Geurts-Moespot A, O'Donovan N, Schmitt M, McGreal G, McDermott E, O'Higgins N, Brünner N, Sweep CG, Duffy MJ.
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction.
    Amowitz LL, Ridker PM, Rifai N, Loughrey CM, Komaroff AL.
    J Womens Health (Larchmt); 2004 Mar; 13(2):165-75; discussion 175. PubMed ID: 15072730
    [Abstract] [Full Text] [Related]

  • 10. Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction.
    Ladenvall P, Johansson L, Jansson JH, Jern S, Nilsson TK, Tjärnlund A, Jern C, Boman K.
    Thromb Haemost; 2002 Jan; 87(1):105-9. PubMed ID: 11848437
    [Abstract] [Full Text] [Related]

  • 11. PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).
    Leander K, Wiman B, Hallqvist J, Sten-Linder M, de Faire U, Stockholm Heart Epidemiology Program.
    Thromb Haemost; 2003 Jun; 89(6):1064-71. PubMed ID: 12783120
    [Abstract] [Full Text] [Related]

  • 12. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G.
    Circulation; 1998 Nov 24; 98(21):2241-7. PubMed ID: 9826309
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of fibrinolytic factors in coronary heart disease.
    Wiman B.
    Scand J Clin Lab Invest Suppl; 1999 Nov 24; 230():23-31. PubMed ID: 10389198
    [Abstract] [Full Text] [Related]

  • 14. Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial.
    Claesson M, Birgander LS, Jansson JH, Lindahl B, Burell G, Asplund K, Mattsson C.
    J Intern Med; 2006 Oct 24; 260(4):320-31. PubMed ID: 16961669
    [Abstract] [Full Text] [Related]

  • 15. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May 24; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

  • 16. Time trends in incidence of myocardial infarction in male and female dominated occupations in Stockholm, Sweden.
    Ostlin P, Klerdal K, Hammar N.
    Scand J Public Health; 2008 Jul 24; 36(5):546-54. PubMed ID: 18635736
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study.
    Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S, INTERHEART Investigators in Latin America.
    Circulation; 2007 Mar 06; 115(9):1067-74. PubMed ID: 17339564
    [Abstract] [Full Text] [Related]

  • 18. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P, Celentano A, Palmieri V, Pezzullo S, Martino S, Bonito M, Guillaro B, Brancati C, Di Minno G.
    Nutr Metab Cardiovasc Dis; 2007 Jul 06; 17(6):468-72. PubMed ID: 17379491
    [Abstract] [Full Text] [Related]

  • 19. Cigarette smoking and myocardial infarction in young men and women: a case-control study.
    Panagiotakos DB, Rallidis LS, Pitsavos C, Stefanadis C, Kremastinos D.
    Int J Cardiol; 2007 Apr 04; 116(3):371-5. PubMed ID: 16843552
    [Abstract] [Full Text] [Related]

  • 20. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study Group.
    Bara L, Nicaud V, Tiret L, Cambien F, Samama MM.
    Thromb Haemost; 1994 Apr 04; 71(4):434-40. PubMed ID: 8052959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.